Ensign Peak Advisors, Inc Vertex Pharmaceuticals Inc Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q2 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 183,704 shares of VRTX stock, worth $92.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

183,704

Previous 224,493 18.17%

Holding current value

$92.3 Million

Previous $93.8 Million 8.24%

% of portfolio

0.16%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $16 Million - $19.8 Million	-40,789 Reduced 18.17%	183,704 $86.1 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $178 Million - $195 Million	-436,034 Reduced 66.01%	224,493 $93.8 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $32.6 Million - $39 Million	-94,975 Reduced 12.57%	660,527 $269 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $4.05 Million - $4.35 Million	-11,990 Reduced 1.56%	755,502 $263 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $5.7 Million - $6.38 Million	18,132 Added 2.42%	767,492 $270 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $91.2 Million - $104 Million	321,980 Added 75.34%	749,360 $236 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $9.06 Million - $10.2 Million	31,689 Added 8.01%	427,380 $123 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $8.44 Million - $9.41 Million	30,810 Added 8.44%	395,691 $115 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $7.42 Million - $9.24 Million	31,572 Added 9.47%	364,881 $103 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $8.33 Million - $9.82 Million	37,631 Added 12.73%	333,309 $87 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $26.8 Million - $33.9 Million	-151,534 Reduced 33.88%	295,678 $64.9 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $28.7 Million - $32.1 Million	-158,321 Reduced 26.15%	447,212 $81.1 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $11.2 Million - $13.2 Million	59,685 Added 10.93%	605,533 $122 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $852,094 - $993,231	4,116 Added 0.76%	545,848 $117 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $8.48 Million - $11.3 Million	40,970 Added 8.18%	541,732 $128 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $31.4 Million - $37.2 Million	-122,808 Reduced 19.69%	500,762 $136 Million
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $39.7 Million - $52 Million	-175,878 Reduced 22.0%	623,570 $181 Million
Q1 2020 May 11, 2020	SELL	$199.77 - $247.81 $2.13 Million - $2.64 Million	-10,669 Reduced 1.32%	799,448 $190 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $135 Million - $181 Million	810,117 New	810,117 $177 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Vertex Pharmaceuticals Inc Transaction History